Report Overview

The Brazil Diabetes Care Market size stood at USD 470 million in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Diabetes is a metabolic condition caused by the inability of the pancreas to produce insulin, which is a hormone that helps the effective absorption of glucose from the food. Some common symptoms include nausea, excessive thirst, extreme hunger, numbness in limbs, dry skin, feeling lethargic, and slow healing of sores. According to the IDF report, the prevalence of Diabetes in Brazil amounted to 11.4%, out of the total population. The total adult population in the country is 147,183,200, while the total number of diabetes cases in adults is approximately 16,780,800.



Market Drivers

A significant rise in awareness amongst consumers regarding the treatment and management of diabetes is one of the major factors driving the market in Brazil. Apart from this, the Brazilian government is focusing on supporting diabetes patients by increasing the budget. Moreover, the government is also improving the availability and affordability both of essential medicines and supplies as well as innovative medicines and technologies.

Other factors, such as the steadily increasing prevalence of diabetes and the introduction of painless and user-friendly insulin delivery methods, are creating a positive outlook for the market across the country.